Insider Transactions in Q2 2023 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
750
+0.02%
|
$12,000
$16.5 P/Share
|
|
Jun 26
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
16,760
+0.66%
|
$268,160
$16.46 P/Share
|
|
Jun 23
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
73,175
+2.83%
|
$1,243,975
$17.43 P/Share
|
|
Jun 22
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,999
+0.29%
|
$118,983
$17.73 P/Share
|
|
Jun 21
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,091
+0.25%
|
$103,547
$17.71 P/Share
|
|
Jun 21
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$8,500
$17.88 P/Share
|
|
Jun 16
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,700
+0.52%
|
$215,900
$17.75 P/Share
|
|
Jun 16
2023
|
Kenneth Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+19.75%
|
-
|
|
Jun 16
2023
|
Matthew L. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+25.08%
|
-
|
|
Jun 16
2023
|
James F Oliviero Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+39.28%
|
-
|
|
Jun 15
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
32,124
+0.66%
|
$546,108
$17.63 P/Share
|
|
Jun 08
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
120
+0.0%
|
$2,040
$17.53 P/Share
|
|
Jun 07
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
230
+0.01%
|
$3,910
$17.41 P/Share
|
|
May 31
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
330
+0.01%
|
$5,610
$17.28 P/Share
|
|
May 24
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.01%
|
$3,400
$17.49 P/Share
|
|
May 16
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
320
+0.01%
|
$5,440
$17.02 P/Share
|